GlassScriptPhysician profile
Sasha White
NPI 1477381911
$2,170.12
in general payments reported to CMS, 2019-2025
17 companies · $1,804 in 2025
The $1,804 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $366 · 2025: $1,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.14 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.23 | 2024-2025 | |
| Janssen Biotech, INC. | $297.79 | 2025 | Tremfya |
| Leo Pharma INC. | $245.43 | 2025 | Adbry, Spevigo, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $233.15 | 2025 | Sotyktu |
| Incyte Corporation | $220.90 | 2024-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $142.13 | 2024-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $126.48 | 2024-2025 | |
| Lilly USA, LLC | $82.92 | 2024-2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $73.66 | 2025 | |
| Ucb, INC. | $72.04 | 2025 | Bimzelx |
| Genzyme Corporation | $36.76 | 2025 | |
| Amgen INC. | $26.19 | 2025 | Otezla |
| Verrica Pharmaceuticals INC. | $23.29 | 2025 | Ycanth |
| Arcutis Biotherapeutics, INC. | $23.05 | 2025 | Zoryve |
| Almirall LLC | $18.36 | 2025 | Klisyri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $16.31 | 2024 | Xepi, Bf-Rhodoled, Rhodoled Xl |
| Krystal Biotech INC | $14.43 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sasha White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.